PALO ALTO, Calif., Sept. 1, 2015 /PRNewswire/ -- Varian Medical
Systems (NYSE: VAR) has added a new cloud-based toolkit to the
company's OncoPeer™ interactive online forum, making development
tools available for research that has the potential to lead to next
generation cancer treatment technologies.
Varian's new Developer Cloud houses digital tools like
information about TrueBeam® Developer Mode, and cloud-based
applications for managing Developer Mode and simulating treatments.
It is part of the company's overall objective to empower
research-oriented clinical teams to accelerate the development of
new treatment techniques and processes designed to improve outcomes
for cancer patients.
"When Varian introduced the TrueBeam platform in 2010, we
included Developer Mode, an optional non-clinical development tool
for researchers to use in pioneering and prototyping new treatment
techniques," said Corey Zankowski,
vice president of products and strategic portfolio management.
"Many important advances have been enabled by the use of this and
other Varian development tools. Developer Cloud was created to
aggregate these developer tools in one place so researchers can
easily access what they need. Researchers can also use the OncoPeer
forum to engage in discussions with other users of the research
tools, to share best practices."
In a separate development, the OncoPeer online forum, first
launched last March in select geographic areas, is now accessible
to Varian customers worldwide. Since March, users have established
discussion groups on topics like oncology analytics,
knowledge-based treatment planning, treatment planning using
Eclipse™ software, and the physics of radiotherapy. One
discussion group focuses on how to use Varian's ARIA® information
system to manage a medical oncology department. Other groups share
information about Varian treatment delivery platforms.
"OncoPeer is a place for customers to find others who use Varian
technology and learn from one another," said Sukhveer Singh, vice president, Varian Oncology
Continuum Solutions. "With the addition of the Developer Cloud,
OncoPeer is now a resource for the research community as
well."
Varian held an online seminar about Navigating OncoPeer last
May. Interested clinicians can view a replay of the webcast at this
registration website. Customers can access OncoPeer at
www.oncopeer.com (registration required).
About Varian Medical Systems
Varian Medical Systems,
Inc., of Palo Alto, California,
focuses energy on saving lives by equipping the world with advanced
technology for fighting cancer and for X-ray imaging. The company
is the world's leading manufacturer of medical devices and software
for treating cancer and other medical conditions with radiation.
The company provides comprehensive solutions for radiotherapy,
radiosurgery, proton therapy and brachytherapy. The company
supplies informatics software for managing comprehensive cancer
clinics, radiotherapy centers and medical oncology practices.
Varian is also a premier supplier of X-ray imaging components,
including tubes, digital detectors, and image processing software
and workstations for use in medical, scientific, and industrial
settings, as well as for security and non-destructive testing.
Varian Medical Systems employs approximately 6,800 people who are
located at manufacturing sites in North
America, Europe, and
China and approximately 70 sales
and support offices around the world. For more information, visit
www.varian.com or follow us on Twitter.
Forward-Looking Statements
Except for historical
information, this news release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Statements concerning industry outlook, including growth
drivers; the ability of the company's technology and products to
treat cancer or improve outcomes; and any statements using the
terms "intended to," "potential," "can," "would," or similar
statements are forward-looking statements that involve risks and
uncertainties that could cause the company's actual results to
differ materially from those anticipated. Such risks and
uncertainties include the effect of global economic conditions;
demand for the company's products; the company's ability to
develop, commercialize, and deploy new products; the company's
ability to meet legal and regulatory requirements; changes in the
legal or regulatory environment; and the other risks listed from
time to time in the company's filings with the Securities and
Exchange Commission, which by this reference are incorporated
herein. The company assumes no obligation to update or revise the
forward-looking statements in this release because of new
information, future events, or otherwise.
Press Contact
Meryl Ginsberg
Varian Medical Systems
+1 (650) 424-6444
meryl.ginsberg@varian.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/varian-puts-research-tools-in-the-cloud-to-speed-development-of-next-generation-cancer-treatment-technologies-300135723.html
SOURCE Varian Medical Systems